News & Perspective

Dec 31, 2012

Dec 31, 2012

FDA approves first med for multidrug-resistant TB

(CIDRAP News) – The US Food and Drug Administration (FDA) today announced its approval of Sirturo (bedaquiline), the first drug developed specifically to treat multidrug-resistant tuberculosis (MDR-TB), saying it must be used in combination with other TB medications.

Nov 27, 2012

Nov 27, 2012

Consumers Union study stirs debate on bacteria in pork

(CIDRAP News) – Consumer Reports magazine has stirred debate about pathogens in pork by reporting a small study in which Yersinia enterocolitica was found in 69% of samples, while more common foodborne pathogens like Salmonella and Listeria were much less prevalent.

Nov 16, 2012

Nov 16, 2012

Europe reports continued rise in antibiotic resistance

(CIDRAP News) – European health officials are seeing a continued rise in multiple antibiotic resistance in Klebsiella pneumoniae and Escherichia coli, a pattern they say is likely fueled by misuse of the drugs, according to new data.

Nov 13, 2012

Nov 13, 2012

Good news, bad news on US antibiotic use and resistance

(CIDRAP News) – Research groups offered a mix of bad news and good news today on antibiotic usage and resistant microbes, including big geographic differences within the United States, as a large coalition of health and medical groups vowed to increase efforts to conserve the nation's arsenal of effective antibiotics.

Oct 18, 2012

Oct 18, 2012

WHO report notes TB progress, areas for concern

(CIDRAP News) – Several developments are having an impact on reducing tuberculosis (TB) infections and deaths in several countries, but the disease's burden is still enormous, and response to multidrug-resistant TB (MDR-TB) remains slow, the World Health Organization (WHO) said yesterday in its latest report on the global TB situation.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»